BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17233858)

  • 21. Cervical intraepithelial neoplasia diagnosis: emotional impact and nursing implications.
    Ferreira SE
    Clin Excell Nurse Pract; 1998 Jul; 2(4):218-24. PubMed ID: 10455565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Initial observation of CIN2 does not appear to reduce quality of life in women under 25 years of age.
    Taghavi K; Morell S; Lamb J; MacNab H; Innes C; Coffey K; Williman J; Simcock B; Sykes P
    Aust N Z J Obstet Gynaecol; 2017 Aug; 57(4):473-478. PubMed ID: 28508566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomised controlled trial to evaluate the effect of self-administered analgesia on women's experience of outpatient treatment at colposcopy.
    Cruickshank ME; Anthony GB; Fitzmaurice A; McConnell D; Graham W; Alexander DA; Tunstall M; Ross JA
    BJOG; 2005 Dec; 112(12):1652-8. PubMed ID: 16305570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conservative management of cervical intraepithelial neoplasia grade 2 (CIN2) in women under 30 years of age: A cohort study.
    Godfrey MAL; Nikolopoulos M; Garner JE; Adib TR; Mukhopadhyay D; Rains JS; Harper CA; Wuntakal R
    Eur J Obstet Gynecol Reprod Biol; 2018 Sep; 228():267-273. PubMed ID: 30048921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small lesion size measured by colposcopy may predict absence of cervical intraepithelial neoplasia in a large loop excision of the transformation zone specimen.
    Munmany M; Marimon L; Cardona M; Nonell R; Juiz M; Astudillo R; Ordi J; Torné A; Del Pino M
    BJOG; 2017 Feb; 124(3):495-502. PubMed ID: 27506510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of age and high-risk human papillomavirus (hrHPV) status on the prevalence of high-grade cervical intraepithelial neoplasia (CIN2+) in women with persistent hrHPV-positive, cytology-negative screening samples: a prospective cohort study.
    Tidy JA; Lyon R; Ellis K; Macdonald M; Palmer JE
    BJOG; 2020 Sep; 127(10):1260-1267. PubMed ID: 32279427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of Cervical Dysplasia After Colposcopy Care and Risk-Informed Return to Population-Based Screening: A Systematic Review.
    Costa-Fagbemi M; Yakubu M; Meggetto O; Moffatt J; Walker MJ; Koné AP; Murphy KJ; Kupets R
    J Obstet Gynaecol Can; 2020 May; 42(5):607-624. PubMed ID: 31679914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
    Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
    PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of post-colposcopy management on women's long-term worries: results from the UK population-based TOMBOLA trial.
    Sharp L; Cotton S; Cruickshank M; Gray N; Smart L; Whynes D; Little J;
    J Fam Plann Reprod Health Care; 2016 Jan; 42(1):43-51. PubMed ID: 26376822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy.
    Cox JT; Schiffman M; Solomon D;
    Am J Obstet Gynecol; 2003 Jun; 188(6):1406-12. PubMed ID: 12824970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The IMproving Primary Screening And Colposcopy Triage trial: human papillomavirus, cervical cytology, and histopathologic results from the baseline and 1-year follow-up phase.
    Safaeian M; Wright TC; Stoler MH; Ranger-Moore J; Rehm S; Aslam S; Fang Q; Volkir P; Ridder R
    Am J Obstet Gynecol; 2021 Sep; 225(3):278.e1-278.e16. PubMed ID: 33852886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Women's colposcopy experience and preferences: a mixed methods study.
    Swancutt DR; Greenfield SM; Wilson S
    BMC Womens Health; 2008 Jan; 8():2. PubMed ID: 18194523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dysplasia severity, but not experiences during colposcopy, predicts adherence to follow-up colposcopy.
    Kola S; Walsh JC
    Psychooncology; 2012 Mar; 21(3):291-6. PubMed ID: 22383271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can default rates in colposcopy really be reduced?
    Balasubramani L; Orbell S; Hagger M; Brown V; Tidy J
    BJOG; 2008 Feb; 115(3):403-8. PubMed ID: 18190379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The borderline cervical smear: colposcopic and biopsy outcome.
    al-Nafussi A; Rebello G; al-Yusif R; McGoogan E
    J Clin Pathol; 2000 Jun; 53(6):439-44. PubMed ID: 10911801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The increased detection of cervical intraepithelial neoplasia when using a second biopsy at colposcopy.
    van der Marel J; van Baars R; Rodriguez A; Quint WG; van de Sandt MM; Berkhof J; Schiffman M; Torné A; Ordi J; Jenkins D; Verheijen RH; Helmerhorst TJ; Ter Harmsel B; Wentzensen N; Del Pino M
    Gynecol Oncol; 2014 Nov; 135(2):201-7. PubMed ID: 25204846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The psychological reaction of women to a colposcopy clinic.
    Roberts RA; Blunt SM
    Br J Obstet Gynaecol; 1994 Sep; 101(9):751-2. PubMed ID: 7677811
    [No Abstract]   [Full Text] [Related]  

  • 38. Optimizing biopsy procedures during colposcopy for women with abnormal cervical cancer screening results: a multicenter prospective study.
    Nakamura Y; Matsumoto K; Satoh T; Nishide K; Nozue A; Shimabukuro K; Endo S; Nagai K; Oki A; Minaguchi T; Morishita Y; Noguchi M; Yoshikawa H
    Int J Clin Oncol; 2015 Jun; 20(3):579-85. PubMed ID: 25145298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subsequent risk and presentation of cervical intraepithelial neoplasia (CIN) 3 or cancer after a colposcopic diagnosis of CIN 1 or less.
    Pretorius RG; Peterson P; Azizi F; Burchette RJ
    Am J Obstet Gynecol; 2006 Nov; 195(5):1260-5. PubMed ID: 17074547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective evaluation of "see and treat" in women with HSIL Pap smear results: is this an appropriate strategy?
    Numnum TM; Kirby TO; Leath CA; Huh WK; Alvarez RD; Straughn JM
    J Low Genit Tract Dis; 2005 Jan; 9(1):2-6. PubMed ID: 15870514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.